Title |
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
|
---|---|
Published in |
Journal of Translational Medicine, October 2020
|
DOI | 10.1186/s12967-020-02573-9 |
Pubmed ID | |
Authors |
Francesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, Carlo Salvarani, Roberto Parrella, Anna Maria Marata, Patrizia Popoli, Laurenzia Ferraris, Massimiliano M. Marrocco-Trischitta, Diego Ripamonti, Francesca Binda, Paolo Bonfanti, Nicola Squillace, Francesco Castelli, Maria Lorenza Muiesan, Miriam Lichtner, Carlo Calzetti, Nicola Duccio Salerno, Luigi Atripaldi, Marco Cascella, Massimo Costantini, Giovanni Dolci, Nicola Cosimo Facciolongo, Fiorentino Fraganza, Marco Massari, Vincenzo Montesarchio, Cristina Mussini, Emanuele Alberto Negri, Gerardo Botti, Claudia Cardone, Piera Gargiulo, Adriano Gravina, Clorinda Schettino, Laura Arenare, Paolo Chiodini, Ciro Gallo |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 60% |
Italy | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 260 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 260 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 26 | 10% |
Student > Bachelor | 24 | 9% |
Researcher | 22 | 8% |
Student > Master | 20 | 8% |
Student > Ph. D. Student | 14 | 5% |
Other | 42 | 16% |
Unknown | 112 | 43% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 60 | 23% |
Nursing and Health Professions | 14 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 14 | 5% |
Biochemistry, Genetics and Molecular Biology | 7 | 3% |
Agricultural and Biological Sciences | 7 | 3% |
Other | 36 | 14% |
Unknown | 122 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 January 2022.
All research outputs
#3,190,886
of 25,010,497 outputs
Outputs from Journal of Translational Medicine
#547
of 4,537 outputs
Outputs of similar age
#78,193
of 426,725 outputs
Outputs of similar age from Journal of Translational Medicine
#23
of 92 outputs
Altmetric has tracked 25,010,497 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,537 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,725 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.